Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Øyen N[au]:

Pregnancy duration and breast cancer risk. Husby A et al. Nat Commun. (2018)

Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study. Øyen N et al. Circulation. (2016)

Preeclampsia and Congenital Heart Defects. Brodwall K et al. JAMA. (2016)

Search results

Items: 1 to 50 of 89

1.

Dietary glycemic index and glycemic load during pregnancy and offspring risk of congenital heart defects: a prospective cohort study.

Schmidt AB, Lund M, Corn G, Halldorsson TI, Øyen N, Wohlfahrt J, Olsen SF, Melbye M.

Am J Clin Nutr. 2020 Jan 14. pii: nqz342. doi: 10.1093/ajcn/nqz342. [Epub ahead of print]

PMID:
31942930
2.

Oral corticosteroids during pregnancy and offspring risk of congenital heart defects: a nationwide cohort study.

Schmidt AB, Lund M, Corn G, Øyen N, Wohlfahrt J, Melbye M.

Int J Epidemiol. 2019 Oct 19. pii: dyz213. doi: 10.1093/ije/dyz213. [Epub ahead of print]

PMID:
31628805
3.

Association Between Maternal Folic Acid Supplementation and Congenital Heart Defects in Offspring in Birth Cohorts From Denmark and Norway.

Øyen N, Olsen SF, Basit S, Leirgul E, Strøm M, Carstensen L, Granström C, Tell GS, Magnus P, Vollset SE, Wohlfahrt J, Melbye M.

J Am Heart Assoc. 2019 Mar 19;8(6):e011615. doi: 10.1161/JAHA.118.011615.

4.

Intake of sucrose-sweetened soft beverages during pregnancy and risk of congenital heart defects (CHD) in offspring: a Norwegian pregnancy cohort study.

Dale MTG, Magnus P, Leirgul E, Holmstrøm H, Gjessing HK, Brodwall K, Haugen M, Stoltenberg C, Øyen N.

Eur J Epidemiol. 2019 Apr;34(4):383-396. doi: 10.1007/s10654-019-00480-y. Epub 2019 Jan 19.

PMID:
30661159
5.

Pregnancy duration and breast cancer risk.

Husby A, Wohlfahrt J, Øyen N, Melbye M.

Nat Commun. 2018 Oct 23;9(1):4255. doi: 10.1038/s41467-018-06748-3.

6.

Paternal characteristics associated with maternal periconceptional use of folic acid supplementation.

Mortensen JHS, Øyen N, Nilsen RM, Fomina T, Tretli S, Bjørge T.

BMC Pregnancy Childbirth. 2018 May 30;18(1):188. doi: 10.1186/s12884-018-1830-1.

7.

The five-year survival of children with Down syndrome in Norway 1994-2009 differed by associated congenital heart defects and extracardiac malformations.

Brodwall K, Greve G, Leirgul E, Klungsøyr K, Holmstrøm H, Vollset SE, Øyen N.

Acta Paediatr. 2018 May;107(5):845-853. doi: 10.1111/apa.14223. Epub 2018 Feb 7.

PMID:
29341296
8.

Response by Boyd et al to Letter Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".

Boyd HA, Basit S, Wohlfahrt J, Øyen N.

Circulation. 2018 Jan 2;137(1):97-98. doi: 10.1161/CIRCULATIONAHA.117.031548. No abstract available.

PMID:
29279343
9.

Recurrence of congenital heart defects among siblings-a nationwide study.

Brodwall K, Greve G, Leirgul E, Tell GS, Vollset SE, Øyen N.

Am J Med Genet A. 2017 Jun;173(6):1575-1585. doi: 10.1002/ajmg.a.38237. Epub 2017 Apr 19.

PMID:
28425218
10.

Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.

Boyd HA, Basit S, Behrens I, Leirgul E, Bundgaard H, Wohlfahrt J, Melbye M, Øyen N.

Circulation. 2017 Jul 4;136(1):39-48. doi: 10.1161/CIRCULATIONAHA.116.024600. Epub 2017 Apr 19.

PMID:
28424221
11.

Maternal Diabetes, Birth Weight, and Neonatal Risk of Congenital Heart Defects in Norway, 1994-2009.

Leirgul E, Brodwall K, Greve G, Vollset SE, Holmstrøm H, Tell GS, Øyen N.

Obstet Gynecol. 2016 Nov;128(5):1116-1125.

PMID:
27741197
12.

Maternal use of folic acid supplements and infant risk of neural tube defects in Norway 1999-2013.

Gildestad T, Øyen N, Klungsøyr K, Nilsen RM, Daltveit AK, Vollset SE.

Scand J Public Health. 2016 Aug;44(6):619-26. doi: 10.1177/1403494816649494. Epub 2016 May 19.

PMID:
27206771
13.

Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study.

Øyen N, Diaz LJ, Leirgul E, Boyd HA, Priest J, Mathiesen ER, Quertermous T, Wohlfahrt J, Melbye M.

Circulation. 2016 Jun 7;133(23):2243-53. doi: 10.1161/CIRCULATIONAHA.115.017465. Epub 2016 May 10.

14.

Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study.

Egeland GM, Klungsøyr K, Øyen N, Tell GS, Næss Ø, Skjærven R.

Hypertension. 2016 Jun;67(6):1173-80. doi: 10.1161/HYPERTENSIONAHA.116.07099. Epub 2016 Apr 25.

15.

Mortality and complications in 3495 children with isolated ventricular septal defects.

Jortveit J, Leirgul E, Eskedal L, Greve G, Fomina T, Døhlen G, Tell GS, Birkeland S, Øyen N, Holmstrøm H.

Arch Dis Child. 2016 Sep;101(9):808-13. doi: 10.1136/archdischild-2015-310154. Epub 2016 Apr 18.

PMID:
27091847
16.

Preeclampsia and Congenital Heart Defects.

Brodwall K, Greve G, Øyen N.

JAMA. 2016 Mar 15;315(11):1167-8. doi: 10.1001/jama.2015.19075. No abstract available.

PMID:
26978216
17.

Supplemental folic acid in pregnancy and childhood cancer risk.

Mortensen JH, Øyen N, Fomina T, Melbye M, Tretli S, Vollset SE, Bjørge T.

Br J Cancer. 2016 Jan 12;114(1):71-5. doi: 10.1038/bjc.2015.446.

18.

Supplemental folic acid in pregnancy and maternal cancer risk.

Mortensen JH, Øyen N, Fomina T, Melbye M, Tretli S, Vollset SE, Bjørge T.

Cancer Epidemiol. 2015 Dec;39(6):805-11. doi: 10.1016/j.canep.2015.10.009. Epub 2015 Oct 18.

19.

Trends in Mortality of Congenital Heart Defects.

Jortveit J, Øyen N, Leirgul E, Fomina T, Tell GS, Vollset SE, Eskedal L, Døhlen G, Birkeland S, Holmstrøm H.

Congenit Heart Dis. 2016 Mar-Apr;11(2):160-8. doi: 10.1111/chd.12307. Epub 2015 Nov 11.

PMID:
26559783
20.

Possible Common Aetiology behind Maternal Preeclampsia and Congenital Heart Defects in the Child: a Cardiovascular Diseases in Norway Project Study.

Brodwall K, Leirgul E, Greve G, Vollset SE, Holmstrøm H, Tell GS, Øyen N.

Paediatr Perinat Epidemiol. 2016 Jan;30(1):76-85. doi: 10.1111/ppe.12252. Epub 2015 Oct 19.

PMID:
26479038
21.

Folic acid supplements and risk for oral clefts in the newborn: a population-based study.

Gildestad T, Bjørge T, Vollset SE, Klungsøyr K, Nilsen RM, Haaland ØA, Øyen N.

Br J Nutr. 2015 Nov 14;114(9):1456-63. doi: 10.1017/S0007114515003013. Epub 2015 Sep 7.

PMID:
26343883
22.

Sudden unexpected death in children with congenital heart defects.

Jortveit J, Eskedal L, Hirth A, Fomina T, Døhlen G, Hagemo P, Tell GS, Birkeland S, Øyen N, Holmstrøm H.

Eur Heart J. 2016 Feb 14;37(7):621-6. doi: 10.1093/eurheartj/ehv478. Epub 2015 Sep 4.

PMID:
26341891
23.

Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons.

Ranthe MF, Carstensen L, Øyen N, Jensen MK, Axelsson A, Wohlfahrt J, Melbye M, Bundgaard H, Boyd HA.

Circulation. 2015 Sep 15;132(11):1013-9. doi: 10.1161/CIRCULATIONAHA.114.013478. Epub 2015 Aug 14.

PMID:
26276887
24.

Periconceptional Folic Acid Supplementation and Infant Risk of Congenital Heart Defects in Norway 1999-2009.

Leirgul E, Gildestad T, Nilsen RM, Fomina T, Brodwall K, Greve G, Vollset SE, Holmstrøm H, Tell GS, Øyen N.

Paediatr Perinat Epidemiol. 2015 Sep;29(5):391-400. doi: 10.1111/ppe.12212. Epub 2015 Jul 24.

PMID:
26212116
25.

Birth prevalence of congenital heart defects in Norway 1994-2009--a nationwide study.

Leirgul E, Fomina T, Brodwall K, Greve G, Holmstrøm H, Vollset SE, Tell GS, Øyen N.

Am Heart J. 2014 Dec;168(6):956-64. doi: 10.1016/j.ahj.2014.07.030. Epub 2014 Aug 10.

26.

Family history of premature death and risk of early onset cardiovascular disease.

Ranthe MF, Carstensen L, Oyen N, Tfelt-Hansen J, Christiansen M, McKenna WJ, Wohlfahrt J, Melbye M, Boyd HA.

J Am Coll Cardiol. 2012 Aug 28;60(9):814-21. doi: 10.1016/j.jacc.2012.06.018.

27.

Familial aggregation of lone atrial fibrillation in young persons.

Oyen N, Ranthe MF, Carstensen L, Boyd HA, Olesen MS, Olesen SP, Wohlfahrt J, Melbye M.

J Am Coll Cardiol. 2012 Sep 4;60(10):917-21. doi: 10.1016/j.jacc.2012.03.046. Epub 2012 Jun 20.

28.
29.

Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up.

Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Øyen N.

J Genet Couns. 2012 Feb;21(1):72-84. doi: 10.1007/s10897-011-9393-6. Epub 2011 Jul 20.

PMID:
21773878
30.

A de novo 1.5 Mb microdeletion on chromosome 14q23.2-23.3 in a patient with autism and spherocytosis.

Griswold AJ, Ma D, Sacharow SJ, Robinson JL, Jaworski JM, Wright HH, Abramson RK, Lybaek H, Øyen N, Cuccaro ML, Gilbert JR, Pericak-Vance MA.

Autism Res. 2011 Jun;4(3):221-7. doi: 10.1002/aur.186. Epub 2011 Feb 28.

31.

Familial aggregation and heritability of pyloric stenosis.

Krogh C, Fischer TK, Skotte L, Biggar RJ, Øyen N, Skytthe A, Goertz S, Christensen K, Wohlfahrt J, Melbye M.

JAMA. 2010 Jun 16;303(23):2393-9. doi: 10.1001/jama.2010.784.

PMID:
20551410
32.

Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

Strømsvik N, Råheim M, Oyen N, Engebretsen LF, Gjengedal E.

J Genet Couns. 2010 Aug;19(4):360-70. doi: 10.1007/s10897-010-9293-1. Epub 2010 Mar 20.

PMID:
20306122
33.

Recurrence of discordant congenital heart defects in families.

Oyen N, Poulsen G, Wohlfahrt J, Boyd HA, Jensen PK, Melbye M.

Circ Cardiovasc Genet. 2010 Apr;3(2):122-8. doi: 10.1161/CIRCGENETICS.109.890103. Epub 2010 Feb 20.

PMID:
20173214
34.

Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Øyen N.

BMC Med Genet. 2010 Feb 17;11:27. doi: 10.1186/1471-2350-11-27.

35.

The clustering of premature deaths in families.

Øyen N, Boyd HA, Poulsen G, Wohlfahrt J, Melbye M.

Epidemiology. 2009 Sep;20(5):757-65. doi: 10.1097/EDE.0b013e3181ad5444.

PMID:
19602981
36.

Recurrence of congenital heart defects in families.

Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M.

Circulation. 2009 Jul 28;120(4):295-301. doi: 10.1161/CIRCULATIONAHA.109.857987. Epub 2009 Jul 13.

PMID:
19597048
37.

[Genetic counseling in congenital long QT syndrome].

Hamang A, Solberg B, Bjorvatn C, Greve G, Øyen N.

Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1226-9. doi: 10.4045/tidsskr.09.32621. Review. Norwegian.

38.

Familial recurrence of midline birth defects--a nationwide danish cohort study.

Oyen N, Boyd HA, Poulsen G, Wohlfahrt J, Melbye M.

Am J Epidemiol. 2009 Jul 1;170(1):46-52. doi: 10.1093/aje/kwp087. Epub 2009 May 4.

PMID:
19414496
39.

National time trends in congenital heart defects, Denmark, 1977-2005.

Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M.

Am Heart J. 2009 Mar;157(3):467-473.e1. doi: 10.1016/j.ahj.2008.10.017. Epub 2008 Dec 23.

PMID:
19249416
40.

Men in the women's world of hereditary breast and ovarian cancer--a systematic review.

Strømsvik N, Råheim M, Oyen N, Gjengedal E.

Fam Cancer. 2009;8(3):221-9. doi: 10.1007/s10689-009-9232-1. Epub 2009 Jan 23.

PMID:
19165626
41.

Infertility and spontaneous abortion among female hairdressers: the Hordaland Health Study.

Baste V, Moen BE, Riise T, Hollund BE, Øyen N.

J Occup Environ Med. 2008 Dec;50(12):1371-7. doi: 10.1097/JOM.0b013e3181858723.

PMID:
19092492
42.

Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.

Berge KE, Haugaa KH, Früh A, Anfinsen OG, Gjesdal K, Siem G, Oyen N, Greve G, Carlsson A, Rognum TO, Hallerud M, Kongsgård E, Amlie JP, Leren TP.

Scand J Clin Lab Invest. 2008;68(5):362-8. doi: 10.1080/00365510701765643.

PMID:
18752142
43.

Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death.

Andersen J, Øyen N, Bjorvatn C, Gjengedal E.

J Genet Couns. 2008 Oct;17(5):489-98. doi: 10.1007/s10897-008-9167-y. Epub 2008 Aug 22.

PMID:
18719982
44.

A 2.1 Mb deletion adjacent but distal to a 14q21q23 paracentric inversion in a family with spherocytosis and severe learning difficulties.

Lybaek H, Øyen N, Fauske L, Houge G.

Clin Genet. 2008 Dec;74(6):553-9. doi: 10.1111/j.1399-0004.2008.01072.x. Epub 2008 Aug 18.

PMID:
18717686
45.

Identification of 34 novel and 56 known FOXL2 mutations in patients with Blepharophimosis syndrome.

Beysen D, De Jaegere S, Amor D, Bouchard P, Christin-Maitre S, Fellous M, Touraine P, Grix AW, Hennekam R, Meire F, Oyen N, Wilson LC, Barel D, Clayton-Smith J, de Ravel T, Decock C, Delbeke P, Ensenauer R, Ebinger F, Gillessen-Kaesbach G, Hendriks Y, Kimonis V, Laframboise R, Laissue P, Leppig K, Leroy BP, Miller DT, Mowat D, Neumann L, Plomp A, Van Regemorter N, Wieczorek D, Veitia RA, De Paepe A, De Baere E.

Hum Mutat. 2008 Nov;29(11):E205-19. doi: 10.1002/humu.20819.

PMID:
18642388
46.

[Hospital admission rates for cardiovascular diseases in Western Norway, 1992-2001].

Øyen N, Nygård O, Igland J, Tell GS, Nordrehaug JE, Irgens LM, Cooper JG, Langørgen J, Vollset SE.

Tidsskr Nor Laegeforen. 2008 Jan 3;128(1):17-23. Norwegian.

47.

Repeated experiences of air hunger and ventilatory behavior in response to hypercapnia in the standardized rebreathing test: effects of anxiety.

Wan L, Van Diest I, De Peuter S, Bogaerts K, Oyen N, Hombroux N, Van de Woestijne K, Gallego J, Van den Bergh O.

Biol Psychol. 2008 Feb;77(2):223-32. Epub 2007 Nov 4.

PMID:
18077078
48.
49.

Maternal epilepsy and offsprings' adult intelligence: a population-based study from Norway.

Øyen N, Vollset SE, Eide MG, Bjerkedal T, Skjaerven R.

Epilepsia. 2007 Sep;48(9):1731-1738. doi: 10.1111/j.1528-1167.2007.01130.x. Epub 2007 May 23.

50.

Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer.

Bjorvatn C, Eide GE, Hanestad BR, Øyen N, Havik OE, Carlsson A, Berglund G.

J Genet Couns. 2007 Apr;16(2):211-22.

PMID:
17279329

Supplemental Content

Support Center